NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

COVID-19診斷的全球市場

COVID-19 Diagnostics: Global Markets

出版商 BCC Research 商品編碼 950329
出版日期 內容資訊 英文 186 Pages
訂單完成後即時交付
價格
COVID-19診斷的全球市場 COVID-19 Diagnostics: Global Markets
出版日期: 2020年07月15日內容資訊: 英文 186 Pages
簡介

到2020年,全球COVID-19診斷市場預計將達到603億美元。預計到2021年至2027年,市場將以15%的複合年增長率增長,到2027年將從2021年的844億美元增長到1,944億美元。預計基於COVID-19的分子測試的複合年增長率為14.8%,血清測試的複合年增長率為15.2%。 (預測期:2021年至2027年)

該報告調查了全球COVID-19診斷市場,包括市場規模,預測,趨勢,增長和限制,按類型,技術,最終用戶和地區,競爭格局以及主要參與者進行的市場分析。我們提供您的個人資料等信息。

內容

第1章簡介

第2章結論/亮點

第3章市場和技術背景

  • 大流行發生概述
  • 發生的歷史
  • COVID-19症狀
  • COVID-19的進展
  • 潛伏期
  • 流行病學
  • 過去的經驗教訓

第4章COVID-19和R&D計劃

  • COVID-19藥物開發的潛在目標
    • Basigin (CD147)
    • C-C Chemokine Receptor Type 5 (CCR5)
    • Envelope Protein (E) (SARS-CoV-2; COVID-19)
    • Epithelial Sodium Channel (ENaC)
    • Histamine N-Methyltransferase (HMT)
    • Interleukin-6 Receptor Subunit alpha (IL-6RA)
    • Membrane Glycoprotein (M) (SARS-CoV-2; COVID-19)
    • Nucleocapsid (N) (SARS-CoV-2; COVID-19)
  • COVID-19的研發
  • 需要重新設計呼吸機
  • COVID-19臨床試驗情況

第5章COVID-19的經濟影響

  • 冠狀病毒對世界經濟的影響
  • 政府在COVID-19上的支出
  • 世界經濟預測
  • COVID-19的社會影響

第6章COVID-19對醫療保健行業的影響

  • COVID-19對藥品供應鏈的影響
  • 終止臨床試驗
  • 對保險提供商的影響
  • 對衛生技術評估的影響
  • 對醫療保健收購的威脅

第7章市場動態

  • 市場增長因素
    • 概述
    • COVID增加19例
    • 政府和私人基金支持COVID-19測試試劑盒和疫苗的研發
    • 增加診斷套件和設備的緊急使用授權(EUA)
    • 增加老年人口
    • 非醫療設備/診斷公司的主要開發和支持
  • 市場約束因素
    • 診斷試劑盒的出口限制
    • 測試結果準確性
  • 市場機會
    • 開發快速,準確且價格合理的檢查
    • 戰略研發計劃

第8章市場細分:按類型

  • 世界市場
  • 分子檢查
  • 血清學檢查

第9章按技術細分的市場

  • 世界市場
  • RT-PCR
  • 等溫擴增
  • CRISPR
  • ELISA
  • 雜交
  • 其他

第10章市場細分:按最終用戶

  • 世界市場
  • 醫院
  • 公共衛生研究所
  • 私人研究所
  • 其他

第11章按地區劃分的市場細分

  • 世界市場
  • 歐洲
  • 北美
  • 亞太地區
  • 拉丁美洲
  • 中東和非洲

第12章COVID-19診斷行業監管結構

  • 冠狀病毒治療加速計劃(CTAP)
  • COVID-19大流行期間正在進行臨床試驗
  • 應對毒品短缺
  • 大流行期間正在進行的臨床試驗的COVID-19國家監管機構

第13章競爭情況

  • 世界公司排名分析
  • 深入瞭解COVID 19診斷的全球市場
  • 競爭
  • 併購
  • 合同,合同,合作,合作
  • 新產品批准

第14章公司簡介

  • 主要診斷製造商
    • ABBOTT
    • BECTON, DICKINSON AND CO.
    • BIOMERIEUX SA
    • BIO-RAD LABORATORIES INC.
    • DANAHER CORP.
    • F. HOFFMANN-LA ROCHE LTD.
    • GENMARK DIAGNOSTICS INC.
    • HOLOGIC INC.
    • QIAGEN NV
    • SIEMENS HEALTHCARE AG
    • THERMO FISHER SCIENTIFIC INC.
  • 其他企業
    • 1DROP DIAGNOSTICS
    • CEPHEID
    • LABORATORY CORPORATION OF AMERICA HOLDINGS
    • PERKINELMER INC.
    • QUEST DIAGNOSTICS
    • VEREDUS LABORATORIES

第15章附錄:縮寫

目錄
Product Code: MDS015A

Highlights:

The global market for COVID-19 diagnostics is valued at $60.3 billion in 2020. The market should grow from $84.4 billion in 2021 to $195.1 billion by 2027, at a compound annual growth rate (CAGR) of 15.0% during 2021-2027.

The global market for COVID-19 based molecular tests should grow from $48.9 billion in 2021 to $112.0 billion by 2027, at a CAGR of 14.8% during 2021-2027.

The global market for COVID-19 based serology tests should grow from $35.5 billion in 2021 to $83.1 billion by 2027, at a CAGR of 15.2% during 2021-2027.

Report Scope:

The current report offers a detailed picture of the market for COVID-19 diagnostics.

COVID-19 is an infectious disease that is caused by the coronavirus and primarily affects the lungs.

This report highlights the current and future market potential for COVID-19 diagnostics and provides a detailed analysis of the competitive environment, regulatory scenario, drivers, restraints, opportunities and trends in the market. The report also covers market projections through 2027, as well as market shares for key market players.

This report details market shares for COVID-19 diagnostics based on type, technology, end-user and geography. Based on type, the market is segmented into molecular tests and serology tests segments. Based on technology, the market is segmented into reverse transcription polymerase chain reaction (RT-PCR), isothermal amplification, clustered regularly interspaced short palindromic repeats (CRISPR), enzyme-linked immunosorbent assay (ELISA), hybridization and others.

By geography, the market has been segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. Detailed analyses of major countries (the U.S., Canada, Germany, the U.K., France, Spain, Italy, Japan, China and India) are covered in regional segments. For market estimates, data has been provided for 2020 as the base year, with forecasts for 2021 through 2027. Estimated values are based on diagnostics manufacturers' total revenues. Projected and forecasted revenue values are in constant U.S. dollars, unadjusted for inflation.

Report Includes:

  • 56 data tables and 39 additional tables
  • An overview of the global market for COVID-19 diagnostics
  • Estimation of the market size of global COVID-19 diagnostics and analyses of global market trends, with estimated data from 2020, 2021 and projections of compound annual growth rates (CAGRs) through 2027
  • Explanation of factors driving and restraining the growth of global COVID-19 diagnostics market
  • A look at the Case-Fatality Rate (CFR), global confirmed cases and confirmed deaths due to COVID-19 and COVID-19 clinical trial landscape
  • Information on potential targets for COVID-19 drug development such as Basigin (CD147), C-C Chemokine Receptor Type 5 (CCR5) and many more
  • Details about collaboration between organizations and governments to stop this pandemic and recent research and development activities for COVID-19
  • Market share analysis of the key companies of the industry, their strategic profiling and key competitive landscape
  • Detailed company profiles of market leading participants, including Abbott, Danaher Corp., Bio-Rad Laboratories Inc., F. Hoffman-La Roche Ltd., and Thermo Fisher Scientific Inc.

Table of Contents

Chapter 1 Introduction

  • Introduction
  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Information Sources
  • Methodology
  • Geographic Breakdown
  • Analyst's Credentials
  • BCC Custom Research
  • Related BCC Research Reports

Chapter 2 Summary and Highlights

Chapter 3 Market and Technology Background

  • Overview of Pandemic Outbreaks
  • History of Outbreak
  • Symptoms of COVID-19
  • Progression of COVID-19
  • Incubation Period
  • Epidemiology
  • Case-Fatality Rate (CFR)
  • Global Confirmed Cases and Confirmed Deaths Due to COVID-19
  • Lessons Learned from the Past
  • Healthcare Worker Infections
  • Collaboration Between Organizations and Governments
  • Spread of the Disease

Chapter 4 COVID-19 and R&D Efforts

  • Potential Targets for COVID-19 Drug Development
  • Basigin (CD147)
  • C-C Chemokine Receptor Type 5 (CCR5)
  • Envelope Protein (E) (SARS-CoV-2; COVID-19)
  • Epithelial Sodium Channel (ENaC)
  • Histamine N-Methyltransferase (HMT)
  • Interleukin-6 Receptor Subunit α (IL-6RA)
  • Membrane Glycoprotein (M) (SARS-CoV-2; COVID-19)
  • Nucleocapsid (N) (SARS-CoV-2; COVID-19)
  • Research and Development on COVID-19
  • Need to Reinvent Ventilators
  • COVID-19 Clinical Trial Landscape

Chapter 5 Economic Impact of COVID-19

  • Impact of Coronavirus on the Global Economy
  • Government Expenditures on COVID-19
  • Predictions for the Global Economy
  • Quick Recovery
  • Global Slowdown
  • Pandemic and Recession
  • Social Impact of COVID-19

Chapter 6 Impact of COVID-19 on the Healthcare Industry

  • Impact of COVID-19 on Pharma Supply Chains
  • Disruption of Clinical Trials
  • Impact on Insurance Providers
  • Impact on Health Technology Assessment
  • Threat to Healthcare Acquisitions

Chapter 7 Market Dynamics

  • Market Drivers
  • Overview
  • Increasing Number of COVID 19 Cases
  • Government and Private Funds to Support Research and Development of COVID-19 Test Kits and Vaccine
  • Rising Number of Emergency Use Authorizations (EUA) for Diagnostic Kits and Devices
  • Growing Geriatric Populations
  • Key Developments and Support by Non-medical Device/Diagnostic Companies
  • Market Restraints
  • Restrictions on Export of Diagnostic Kits
  • Accuracy of Test Results
  • Market Opportunities
  • Development of Quick, Accurate and Affordable Tests
  • Strategic R&D Initiatives

Chapter 8 Market Breakdown by Type

  • Global Market for COVID-19 Diagnostics by Type
  • Molecular Tests
  • Market Size and Forecast
  • Serology Tests
  • Market Size and Forecast

Chapter 9 Market Breakdown by Technology

  • Global Market for COVID-19 Diagnostics by Technology
  • RT-PCR
  • Market Size and Forecast
  • Isothermal Amplification
  • Market Size and Forecast
  • CRISPR
  • Market Size and Forecast
  • ELISA
  • Market Size and Forecast
  • Hybridization
  • Market Size and Forecast
  • Others
  • Market Size and Forecast

Chapter 10 Market Breakdown by End User

  • Global Market for COVID-19 Diagnostics by End User
  • Hospitals
  • Market Size and Forecast
  • Public Health Laboratories
  • Market Size and Forecast
  • Private Laboratories
  • Market Size and Forecast
  • Others
  • Market Size and Forecast

Chapter 11 Market Breakdown by Region

  • Global Market for COVID-19 Diagnostics by Region
  • Europe
  • United Kingdom
  • Spain
  • Germany
  • Italy
  • France
  • Rest of Western Europe
  • Eastern Europe
  • North America
  • United States
  • Canada
  • Asia-Pacific
  • India
  • Australia
  • South Korea
  • Japan
  • China
  • Rest of Asia-Pacific
  • Latin America
  • Market Size and Forecast
  • Market Analysis
  • Middle East and Africa
  • Market Size and Forecast

Chapter 12 Regulatory Structure of the COVID-19 Diagnostics Industry

  • Coronavirus Treatment Acceleration Program (CTAP)
  • Clinical Trials Being Conducted During COVID-19 Pandemic
  • Drug Shortages Response
  • National Regulatory Agencies for Ongoing Clinical Trials During the COVID-19 Pandemic
  • U.S. FDA
  • Medicines and Healthcare Products Regulatory Agency (U.K.)
  • European Medicines Agency

Chapter 13 Competitive Landscape

  • Global Company Ranking Analysis
  • Insights into the Global Market for COVID 19 Diagnostics
  • Competitors
  • Mergers and Acquisitions
  • Agreements, Contracts, Collaborations and Partnerships
  • New Product Approvals

Chapter 14 Company Profiles

  • Major Diagnostics Manufacturers
  • ABBOTT
  • BECTON, DICKINSON AND CO.
  • BIOMERIEUX SA
  • BIO-RAD LABORATORIES INC.
  • DANAHER CORP.
  • F. HOFFMANN-LA ROCHE LTD.
  • GENMARK DIAGNOSTICS INC.
  • HOLOGIC INC.
  • QIAGEN NV
  • SIEMENS HEALTHCARE AG
  • THERMO FISHER SCIENTIFIC INC.
  • Other Prominent Companies
  • 1DROP DIAGNOSTICS
  • CEPHEID
  • LABORATORY CORPORATION OF AMERICA HOLDINGS
  • PERKINELMER INC.
  • QUEST DIAGNOSTICS
  • VEREDUS LABORATORIES

Chapter 15 Appendix: Acronyms

List of Tables

  • Summary Table B: Global Market for COVID-19 Diagnostics, by Technology, Through 2027
  • Summary Table A: Global Market for COVID-19 Diagnostics, by Type, Through 2027
    • Table 1: COVID-19 Symptoms, by Percentage of Patients
    • Table 2: COVID-19 CFR, by Region, as of March 2020
    • Table 3: COVID-19 CFR, by Selected Countries, as of March 2020
    • Table 4: COVID-19 Confirmed Cases and Deaths, by Country, as of April 15, 2020
    • Table 5: COVID-19 Cases and Deaths per 1 Million Population, by Selected Country
    • Table 6: Total Number of Diagnostic Tests Performed per 1 Million Population, by Selected Country
    • Table 7: COVID-19 Therapeutic Interventions in Development, by Biopharmaceutical Company Collaborations
    • Table 8: COVID-19 Therapeutics in Development, by Biopharmaceutical Company
    • Table 9: COVID-19 Vaccines in Development, by Biopharmaceutical Companies in Collaboration
    • Table 10: COVID-19 Vaccines in Development, by Biopharmaceutical Company
    • Table 11: Modifiable Breathing Devices Eligible for Emergency Use Authorization (EUA), by Company
    • Table 12: Clinical Trials on COVID-19, by Phase
    • Table 13: Clinical Trials on COVID-19, by Intervention
    • Table 14: Clinical Trials on COVID-19, by Country
    • Table 15: Interim Economic Outlook Forecasts, by Country/Region, as of March 2, 2020
    • Table 16: Expenditures on COVID-19 Crisis
    • Table 17: Disruption of Clinical Trials Due to COVID-19, by Therapeutic Area
    • Table 18: Selected Pending Acquisitions in the Healthcare Industry
    • Table 19: Global COVID 19 Virus Scenario, as of May 20, 2020
    • Table 20: Test Kit Manufacturers and EUA Authorizations
    • Table 21: Global Market for COVID-19 Diagnostics, by Type, Through 2027
    • Table 22: U.S. FDA Revised Policy for COVID-19 Molecular Tests During the Public Health Emergency, by Company
    • Table 23: Global Market for COVID-19 Molecular Tests, by Region, Through 2027
    • Table 24: U.S. FDA Revised Policy for COVID-19 Serological Tests During the Public Health Emergency, by Company
    • Table 25: Global Market for COVID-19 Serological Tests, by Region, Through 2027
    • Table 26: Global Market for COVID-19 Diagnostics, by Technology, Through 2027
    • Table 27: Global Market for COVID-19 RT-PCR Diagnostics, by Region, Through 2027
    • Table 28: U.S. FDA Revised Policy for COVID-19 During the Public Health Emergency: Usage of Isothermal Amplification Technology, by Company
    • Table 29: Global Market for COVID-19 Isothermal Amplification Diagnostics, by Region, Through 2027
    • Table 30: Global Market for COVID-19 CRISPR Diagnostics, by Region, Through 2027
    • Table 31: U.S. FDA Revised Policy for COVID-19 during Public Health Emergency: Usage of ELISA, by Company
    • Table 32: Global Market for COVID-19 ELISA Diagnostics, by Region, Through 2027
    • Table 33: Global Market for COVID-19 Hybridization Diagnostics, by Region, Through 2027
    • Table 34: Global Market for Other Types of COVID-19 Diagnostics, by Region, Through 2027
    • Table 35: Global Market for COVID-19 Diagnostics, by End User, Through 2027
    • Table 36: Global Market for COVID-19 Diagnostics in Hospitals, by Region, Through 2027
    • Table 37: Global Market for COVID-19 Diagnostics in Public Health Laboratories, by Region, Through 2027
    • Table 38: Global Market for COVID-19 Diagnostics in Private Laboratories, by Region, Through 2027
    • Table 39: Global Market for COVID-19 Diagnostics in the Other End-User Segment, by Region, Through 2027
    • Table 40: Global Market for COVID-19 Diagnostics, by Region, Through 2027
    • Table 41: European Market for COVID-19 Diagnostics, by Sub-region, Through 2027
    • Table 42: European Market for COVID-19 Diagnostics, by Type, Through 2027
    • Table 43: Western European Market for COVID-19 Diagnostics, by Country, Through 2027
    • Table 44: North American Market for COVID-19 Diagnostics, by Type, Through 2027
    • Table 45: North American Market for COVID-19 Diagnostics, by Country, Through 2027
    • Table 46: Asia-Pacific Market for COVID-19 Diagnostics, by Type, Through 2027
    • Table 47: Asia-Pacific Market for COVID-19 Diagnostics, by Country, Through 2027
    • Table 48: Latin American Market for COVID-19 Diagnostics, by Type, Through 2027
    • Table 49: Middle Eastern and African Market for COVID-19 Diagnostics, by Type, Through 2027
    • Table 50: Global Company Ranking within the Market for COVID-19 Diagnostics, 2020
    • Table 51: Competitors in the Market for COVID-19 Diagnostics
    • Table 52: Recent Acquisitions by Players in the Market for COVID-19 Diagnostics, 2016 and 2017
    • Table 53: Recent Contracts in the Market for COVID-19 Diagnostics, 2020
    • Table 54: Recent Product Approvals on COVID-19 Diagnostics, 2020
    • Table 55: Abbott: Financials, 2016-2019
    • Table 56: Abbott: Product Portfolio, by Business Segment
    • Table 57: Abbott: Rhythm Management Products, 2018
    • Table 58: Abbott: Recent Developments, April 2015-April 2020
    • Table 59: Becton, Dickinson and Co.: Financials, 2019
    • Table 60: Becton, Dickinson and Co.: Product Portfolio
    • Table 61: Becton, Dickinson and Co.: Bioscience Cell Culture Product Portfolio
    • Table 62: Becton, Dickinson and Co.: Recent Developments, August 2015-April 2020
    • Table 63: BioMerieux SA: Financials, 2018
    • Table 64: BioMerieux SA: Products and Services
    • Table 65: BioMerieux SA: Recent Developments, November 2018-March 2020
    • Table 66: Bio-Rad Laboratories Inc.: Financials, 2019
    • Table 67: Bio-Rad Laboratories Inc.: Products and Services
    • Table 68: Bio-Rad Laboratories Inc.: Recent Developments, January 2018-May 2020
    • Table 69: Danaher Corp.: Product Portfolio
    • Table 70: Danaher Corp.: Financials, 2019
    • Table 71: Danaher Corp.: Products and Services
    • Table 72: Danaher Corp.: Recent Developments, August 2015-March 2020
    • Table 73: F. Hoffmann-La Roche Ltd.: Financials, 2019
    • Table 74: F. Hoffmann-La Roche Ltd.: Revenues, by Segment, 2016-2018
    • Table 75: F. Hoffmann-La Roche Ltd.: Revenue, by Diagnostic Segment, 2016-2018
    • Table 76: F. Hoffmann-La Roche Ltd.: Product Portfolio
    • Table 77: F. Hoffmann-La Roche Ltd.: Diagnostics Patient Monitoring Product Portfolio
    • Table 78: F. Hoffmann-La Roche Ltd.: Recent Developments, January 2015-April 2020
    • Table 79: GenMark Diagnostics Inc.: Key Products
    • Table 80: GenMark Diagnostics Inc.: COVID Diagnostic Product
    • Table 81: Glenmark Diagnostics Inc.: Financials, 2019
    • Table 82: Glenmark Diagnostics Inc.: Recent Developments, March 2020
    • Table 83: Hologic Inc.: Financials, 2019
    • Table 84: Hologic Inc.: Recent Developments and Strategies, March 2017-March 2020
    • Table 85: Qiagen NV: Financials, 2016 and 2017
    • Table 86: Qiagen NV: Products and Services
    • Table 87: Siemens Healthcare AG: Key Products
    • Table 88: Siemens Healthcare AG: Product Segments
    • Table 89: Siemens Healthcare AG: Financials, 2019
    • Table 90: Siemens Healthcare AG: Recent Developments, March 2016-March 2020
    • Table 91: Thermo Fisher Scientific Inc.: Financials, 2018-2019
    • Table 92: Thermo Fisher Scientific Inc.: Products and Services
    • Table 93: Acronyms Used in This Report

List of Figures

  • Summary Figure A: Global Market Shares of COVID-19 Diagnostics, by Type, 2020
  • Summary Figure B: Global Market Shares of COVID-19 Diagnostics, by Technology, 2020
    • Figure 1: Infographic Comparison of the CFRs of the Three Major Beta Coronaviruses: MERS, SARS and COVID-19
    • Figure 2: Distribution of Clinical Trials on COVID-19, by Phase
    • Figure 3: Distribution of Clinical Trials on COVID-19, by Intervention
    • Figure 4: Distribution of Clinical Trials on COVID-19, by Country
    • Figure 5: Comparison of GDP Growth Globally, 2019 vs. 2020
    • Figure 6: Global Healthcare Performance, by Financial Times Stock Exchange (FTSE)
    • Figure 7: Distribution of the Disruption of Clinical Trials Due to COVID-19, by Therapeutic Area
    • Figure 8: Global Market Shares of COVID-19 Diagnostics, by Type, 2020
    • Figure 9: Global Market for COVID-19 Molecular Tests, 2020-2027
    • Figure 10: Global Market for COVID-19 Molecular Tests, by Region, 2020-2027
    • Figure 11: Global Market for COVID-19 Serological Tests, 2020-2027
    • Figure 12: Global Market for COVID-19 Serological Tests, by Region, 2020-2027
    • Figure 13: Global Market Shares of COVID-19 Diagnostics, by Technology, 2020
    • Figure 14: Global Market for COVID-19 RT-PCR Diagnostics, 2020-2027
    • Figure 15: Global Market for COVID-19 RT-PCR Diagnostics, by Region, 2020-2027
    • Figure 16: Global Market for COVID-19 Isothermal Amplification Diagnostics, 2020-2027
    • Figure 17: Global Market for COVID-19 Isothermal Amplification Diagnostics, by Region, 2020-2027
    • Figure 18: Global Market for COVID-19 CRISPR Diagnostics, 2020-2027
    • Figure 19: Global Market for COVID-19 CRISPR Diagnostics, by Region, 2020-2027
    • Figure 20: Global Market for COVID-19 ELISA Diagnostics, 2020-2027
    • Figure 21: Global Market for COVID-19 ELISA Diagnostics, by Region, 2020-2027
    • Figure 22: Global Market for COVID-19 Hybridization Diagnostics, 2020-2027
    • Figure 23: Global Market for COVID-19 Hybridization Diagnostics, by Region, 2020-2027
    • Figure 24: Global Market for Other Types of COVID-19 Diagnostics, 2020-2027
    • Figure 25: Global Market for Other Types of COVID-19 Diagnostics, by Region, 2020-2027
    • Figure 26: Global Market Shares of COVID-19 Diagnostics, by End User, 2020
    • Figure 27: Global Market for COVID-19 Diagnostics in Hospitals, 2020-2027
    • Figure 28: Global Market for COVID-19 Diagnostics in Hospitals, by Region, 2020-2027
    • Figure 29: Global Market for COVID-19 Diagnostics in Public Health Laboratories, 2020-2027
    • Figure 30: Global Market for COVID-19 Diagnostics in Public Health Laboratories, by Region, 2020-2027
    • Figure 31: Global Market for COVID-19 Diagnostics in Public Health Laboratories, 2020-2027
    • Figure 32: Global Market for COVID-19 Diagnostics in Private Laboratories, by Region, 2020-2027
    • Figure 33: Global Market for COVID-19 Diagnostics in the Other End-User Segment, 2020-2027
    • Figure 34: Global Market for COVID-19 Diagnostics in the Other End-User Segment, by Region, 2020-2027
    • Figure 35: Global Market Shares of COVID-19 Diagnostics, by Region, 2020
    • Figure 36: European Market Shares of COVID-19 Diagnostics, by Sub-region, 2020
    • Figure 37: European Market Shares of COVID-19 Diagnostics, by Type, 2020
    • Figure 38: Western European Market Shares of COVID-19 Diagnostics, by Country, 2020
    • Figure 39: U.K. Market for COVID-19 Diagnostics, 2020-2027
    • Figure 40: Spanish Market for COVID-19 Diagnostics, 2020-2027
    • Figure 41: German Market for COVID-19 Diagnostics, 2020-2027
    • Figure 42: Italian Market for COVID-19 Diagnostics, 2020-2027
    • Figure 43: French Market for COVID-19 Diagnostics, 2020-2027
    • Figure 44: Rest of Western European Market for COVID-19 Diagnostics, 2020-2027
    • Figure 45: Eastern European Market for COVID-19 Diagnostics, 2020-2027
    • Figure 46: North American Market Shares of COVID-19 Diagnostics, by Type, 2020
    • Figure 47: North American Market Shares of COVID-19 Diagnostics, by Country, 2020
    • Figure 48: U.S. Market for COVID-19 Diagnostics, 2020-2027
    • Figure 49: Canadian Market for COVID-19 Diagnostics, 2020-2027
    • Figure 50: Asia-Pacific Market Shares of COVID-19 Diagnostics, by Type, 2020
    • Figure 51: Asia-Pacific Market Shares of COVID-19 Diagnostics, by Country, 2020
    • Figure 52: Indian Market for COVID-19 Diagnostics, 2020-2027
    • Figure 53: Australian Market for COVID-19 Diagnostics, 2020-2027
    • Figure 54: South Korean Market for COVID-19 Diagnostics, 2020-2027
    • Figure 55: Japanese Market for COVID-19 Diagnostics, 2020-2027
    • Figure 56: Chinese Market for COVID-19 Diagnostics, 2020-2027
    • Figure 57: Rest of Asia-Pacific Market for COVID-19 Diagnostics, 2020-2027
    • Figure 58: Latin American Market for COVID-19 Diagnostics, 2020-2027
    • Figure 59: Latin American Market Shares of COVID-19 Diagnostics, by Type, 2020
    • Figure 60: Middle Eastern and African Market for COVID-19 Diagnostics, 2020-2027
    • Figure 61: Middle Eastern and African Market Shares of COVID-19 Diagnostics, by Type, 2020
    • Figure 62: Abbott: Revenue Share, by Region, 2019
    • Figure 63: Abbott: Revenue Share, by Business Segment, 2019
    • Figure 64: Abbott: R&D Expenditure, 2015-2019
    • Figure 65: Becton, Dickinson and Co.: Revenue Share, by Business Unit, 2019
    • Figure 66: Becton, Dickinson and Co.: Revenue Share, by Region, 2019
    • Figure 67: BioMerieux SA: Revenue, by Business Segment, 2015-2017
    • Figure 68: BioMerieux SA: Revenue, by Region, 2015-2017
    • Figure 69: Bio-Rad Laboratories Inc.: Revenue, by Business Segment, 2015-2019
    • Figure 70: Bio-Rad Laboratories Inc.: Revenue, by Region, 2015-2019
    • Figure 71: Bio-Rad Laboratories Inc.: Revenue Share, by Region, 2019
    • Figure 72: Danaher Corp.: Revenue Share, by Segment, 2019
    • Figure 73: Danaher Corp.: Revenue Share, by Region, 2019
    • Figure 74: F. Hoffmann-La Roche Ltd.: Revenue Share, by Segment, 2019
    • Figure 75: F. Hoffmann-La Roche Ltd.: Revenue Share, by Region, 2019
    • Figure 76: Glenmark Diagnostics Inc.: Revenue Share, by Business Segment, 2019
    • Figure 77: Hologic Inc.: Financials, 2014-2019
    • Figure 78: Hologic Inc.: Revenue Share, by Region, 2019
    • Figure 79: Hologic Inc.: Revenue Share, by Segment, 2019
    • Figure 80: Qiagen NV: Net Sales Share, by Region, 2017
    • Figure 81: Siemens Healthcare AG: Revenue Share, by Business Segment, 2019
    • Figure 82: Siemens Healthcare AG: Revenue Share, by Region, 2019
    • Figure 83: Thermo Fisher Scientific Inc.: Revenue Share, by Business Segment, 2019